SPY technology as an adjunctive measure for lower extremity perfusion

Objective Lack of a reliable outcome measure often leads to excessive or insufficient interventions for critical limb ischemia (CLI). SPY technology (Novadaq Technologies Inc, Bonita Springs, Fla), widely adapted by plastic and general surgeons, uses laser-assisted fluorescence angiography (LAFA) to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of vascular surgery 2016-07, Vol.64 (1), p.195-201
Hauptverfasser: Colvard, Benjamin, MD, Itoga, Nathan K., MD, Hitchner, Elizabeth, MS, Sun, Qingfeng, MD, Long, Becky, MD, Lee, George, MD, Chandra, Venita, MD, Zhou, Wei, MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 201
container_issue 1
container_start_page 195
container_title Journal of vascular surgery
container_volume 64
creator Colvard, Benjamin, MD
Itoga, Nathan K., MD
Hitchner, Elizabeth, MS
Sun, Qingfeng, MD
Long, Becky, MD
Lee, George, MD
Chandra, Venita, MD
Zhou, Wei, MD
description Objective Lack of a reliable outcome measure often leads to excessive or insufficient interventions for critical limb ischemia (CLI). SPY technology (Novadaq Technologies Inc, Bonita Springs, Fla), widely adapted by plastic and general surgeons, uses laser-assisted fluorescence angiography (LAFA) to assess tissue perfusion. We sought to determine the role of SPY as an alternative, perhaps more reliable outcome measure for vascular interventions. Methods All patients undergoing elective or urgent revascularization for claudication and CLI were prospectively recruited from June 2012 to August 2014. LAFA using SPY technology was performed before and after revascularization procedures under a standard Institutional Review Board-approved protocol. Quantitative measures of perfusion at plantar surfaces were analyzed and compared with ankle-brachial index. Results A total of 93 patients with claudication or CLI underwent LAFA before and after a revascularization procedure in the study period. The mean preoperative ankle-brachial index increased from 0.60 to 0.84 ( P  < .001) after a revascularization procedure. Plantar perfusion as measured by LAFA also improved significantly after intervention. Ingress, defined as the rate at which fluorescence intensity increases on the plantar surface during LAFA, increased from 7.1 to 12.4 units/s ( P  < .001). Peak perfusion, defined as the difference between the baseline and the peak of fluorescence intensity, increased from 97.1 and 143.9 units ( P  < .001). Egress, defined as the rate at which intensity diminishes after reaching peak perfusion, increased from 1.0 to 1.9 units/s ( P  = .035). Procedure-related digital embolization was also observed in several patients despite lack of an angiographic finding. Conclusions This is the largest prospective study evaluating SPY technology in peripheral vascular interventions. Our study shows that SPY is a valuable tool in visualizing real-time procedural outcomes and providing additionally useful information on regional tissue perfusion. Further investigation is warranted to standardize outpatient use and to determine threshold values that predict wound healing.
doi_str_mv 10.1016/j.jvs.2016.01.039
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6706067</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0741521416001671</els_id><sourcerecordid>1800130157</sourcerecordid><originalsourceid>FETCH-LOGICAL-c506t-70597ac9224310f6dc95fe1dcb63f4c0848739297ce6467874753d4dd0797c0e3</originalsourceid><addsrcrecordid>eNp9kUtv1TAQhS1ERS-FH8AGZckmYZyHHQupEqrKQ6pUpMKC1ch1Jq1DYl_s5ML99zi6pWpZsPLIPueM5xvGXnEoOHDxdiiGXSzKVBbAC6jUE7bhoGQuWlBP2QZkzfOm5PUxex7jAMB508pn7LgUStWqURt2fvXlezaTuXV-9Df7TMdMu0x3w-LMbHeUTaTjEijrfchG_4tCRr_nQJOd99mWQr9E690LdtTrMdLLu_OEfftw_vXsU35x-fHz2fuL3DQg5lxCo6Q2qizrikMvOqOannhnrkXV1wbaupWVKpU0JGohW1nLpurqrgOZ7oCqE3Z6yN0u1xN1htwc9IjbYCcd9ui1xccvzt7ijd-hkCBAyBTw5i4g-J8LxRknGw2No3bkl4i8TZAq4M0q5QepCT7GQP19Gw644scBE35c8SNwTPiT5_XD_907_vJOgncHASVKO0sBo7HkDHU2kJmx8_a_8af_uM1onTV6_EF7ioNfgkv4kWMsEfBq3f-6fi7SVELy6g-4f6s5</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1800130157</pqid></control><display><type>article</type><title>SPY technology as an adjunctive measure for lower extremity perfusion</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Colvard, Benjamin, MD ; Itoga, Nathan K., MD ; Hitchner, Elizabeth, MS ; Sun, Qingfeng, MD ; Long, Becky, MD ; Lee, George, MD ; Chandra, Venita, MD ; Zhou, Wei, MD</creator><creatorcontrib>Colvard, Benjamin, MD ; Itoga, Nathan K., MD ; Hitchner, Elizabeth, MS ; Sun, Qingfeng, MD ; Long, Becky, MD ; Lee, George, MD ; Chandra, Venita, MD ; Zhou, Wei, MD</creatorcontrib><description>Objective Lack of a reliable outcome measure often leads to excessive or insufficient interventions for critical limb ischemia (CLI). SPY technology (Novadaq Technologies Inc, Bonita Springs, Fla), widely adapted by plastic and general surgeons, uses laser-assisted fluorescence angiography (LAFA) to assess tissue perfusion. We sought to determine the role of SPY as an alternative, perhaps more reliable outcome measure for vascular interventions. Methods All patients undergoing elective or urgent revascularization for claudication and CLI were prospectively recruited from June 2012 to August 2014. LAFA using SPY technology was performed before and after revascularization procedures under a standard Institutional Review Board-approved protocol. Quantitative measures of perfusion at plantar surfaces were analyzed and compared with ankle-brachial index. Results A total of 93 patients with claudication or CLI underwent LAFA before and after a revascularization procedure in the study period. The mean preoperative ankle-brachial index increased from 0.60 to 0.84 ( P  &lt; .001) after a revascularization procedure. Plantar perfusion as measured by LAFA also improved significantly after intervention. Ingress, defined as the rate at which fluorescence intensity increases on the plantar surface during LAFA, increased from 7.1 to 12.4 units/s ( P  &lt; .001). Peak perfusion, defined as the difference between the baseline and the peak of fluorescence intensity, increased from 97.1 and 143.9 units ( P  &lt; .001). Egress, defined as the rate at which intensity diminishes after reaching peak perfusion, increased from 1.0 to 1.9 units/s ( P  = .035). Procedure-related digital embolization was also observed in several patients despite lack of an angiographic finding. Conclusions This is the largest prospective study evaluating SPY technology in peripheral vascular interventions. Our study shows that SPY is a valuable tool in visualizing real-time procedural outcomes and providing additionally useful information on regional tissue perfusion. Further investigation is warranted to standardize outpatient use and to determine threshold values that predict wound healing.</description><identifier>ISSN: 0741-5214</identifier><identifier>EISSN: 1097-6809</identifier><identifier>DOI: 10.1016/j.jvs.2016.01.039</identifier><identifier>PMID: 26994959</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Aged ; Aged, 80 and over ; Ankle Brachial Index ; Blood Flow Velocity ; Critical Illness ; Embolism - diagnosis ; Embolism - etiology ; Embolism - physiopathology ; Female ; Fluorescein Angiography - instrumentation ; Fluorescent Dyes - administration &amp; dosage ; Humans ; Indocyanine Green - administration &amp; dosage ; Injections, Intravenous ; Intermittent Claudication - diagnosis ; Intermittent Claudication - physiopathology ; Intermittent Claudication - therapy ; Ischemia - diagnosis ; Ischemia - physiopathology ; Ischemia - therapy ; Lasers ; Lower Extremity - blood supply ; Male ; Middle Aged ; Perfusion Imaging - instrumentation ; Perfusion Imaging - methods ; Peripheral Arterial Disease - diagnosis ; Peripheral Arterial Disease - physiopathology ; Peripheral Arterial Disease - therapy ; Predictive Value of Tests ; Prospective Studies ; Regional Blood Flow ; Reproducibility of Results ; Surgery ; Time Factors ; Treatment Outcome ; Vascular Patency</subject><ispartof>Journal of vascular surgery, 2016-07, Vol.64 (1), p.195-201</ispartof><rights>2016</rights><rights>Published by Elsevier Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c506t-70597ac9224310f6dc95fe1dcb63f4c0848739297ce6467874753d4dd0797c0e3</citedby><cites>FETCH-LOGICAL-c506t-70597ac9224310f6dc95fe1dcb63f4c0848739297ce6467874753d4dd0797c0e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jvs.2016.01.039$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,777,781,882,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26994959$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Colvard, Benjamin, MD</creatorcontrib><creatorcontrib>Itoga, Nathan K., MD</creatorcontrib><creatorcontrib>Hitchner, Elizabeth, MS</creatorcontrib><creatorcontrib>Sun, Qingfeng, MD</creatorcontrib><creatorcontrib>Long, Becky, MD</creatorcontrib><creatorcontrib>Lee, George, MD</creatorcontrib><creatorcontrib>Chandra, Venita, MD</creatorcontrib><creatorcontrib>Zhou, Wei, MD</creatorcontrib><title>SPY technology as an adjunctive measure for lower extremity perfusion</title><title>Journal of vascular surgery</title><addtitle>J Vasc Surg</addtitle><description>Objective Lack of a reliable outcome measure often leads to excessive or insufficient interventions for critical limb ischemia (CLI). SPY technology (Novadaq Technologies Inc, Bonita Springs, Fla), widely adapted by plastic and general surgeons, uses laser-assisted fluorescence angiography (LAFA) to assess tissue perfusion. We sought to determine the role of SPY as an alternative, perhaps more reliable outcome measure for vascular interventions. Methods All patients undergoing elective or urgent revascularization for claudication and CLI were prospectively recruited from June 2012 to August 2014. LAFA using SPY technology was performed before and after revascularization procedures under a standard Institutional Review Board-approved protocol. Quantitative measures of perfusion at plantar surfaces were analyzed and compared with ankle-brachial index. Results A total of 93 patients with claudication or CLI underwent LAFA before and after a revascularization procedure in the study period. The mean preoperative ankle-brachial index increased from 0.60 to 0.84 ( P  &lt; .001) after a revascularization procedure. Plantar perfusion as measured by LAFA also improved significantly after intervention. Ingress, defined as the rate at which fluorescence intensity increases on the plantar surface during LAFA, increased from 7.1 to 12.4 units/s ( P  &lt; .001). Peak perfusion, defined as the difference between the baseline and the peak of fluorescence intensity, increased from 97.1 and 143.9 units ( P  &lt; .001). Egress, defined as the rate at which intensity diminishes after reaching peak perfusion, increased from 1.0 to 1.9 units/s ( P  = .035). Procedure-related digital embolization was also observed in several patients despite lack of an angiographic finding. Conclusions This is the largest prospective study evaluating SPY technology in peripheral vascular interventions. Our study shows that SPY is a valuable tool in visualizing real-time procedural outcomes and providing additionally useful information on regional tissue perfusion. Further investigation is warranted to standardize outpatient use and to determine threshold values that predict wound healing.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Ankle Brachial Index</subject><subject>Blood Flow Velocity</subject><subject>Critical Illness</subject><subject>Embolism - diagnosis</subject><subject>Embolism - etiology</subject><subject>Embolism - physiopathology</subject><subject>Female</subject><subject>Fluorescein Angiography - instrumentation</subject><subject>Fluorescent Dyes - administration &amp; dosage</subject><subject>Humans</subject><subject>Indocyanine Green - administration &amp; dosage</subject><subject>Injections, Intravenous</subject><subject>Intermittent Claudication - diagnosis</subject><subject>Intermittent Claudication - physiopathology</subject><subject>Intermittent Claudication - therapy</subject><subject>Ischemia - diagnosis</subject><subject>Ischemia - physiopathology</subject><subject>Ischemia - therapy</subject><subject>Lasers</subject><subject>Lower Extremity - blood supply</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Perfusion Imaging - instrumentation</subject><subject>Perfusion Imaging - methods</subject><subject>Peripheral Arterial Disease - diagnosis</subject><subject>Peripheral Arterial Disease - physiopathology</subject><subject>Peripheral Arterial Disease - therapy</subject><subject>Predictive Value of Tests</subject><subject>Prospective Studies</subject><subject>Regional Blood Flow</subject><subject>Reproducibility of Results</subject><subject>Surgery</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><subject>Vascular Patency</subject><issn>0741-5214</issn><issn>1097-6809</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kUtv1TAQhS1ERS-FH8AGZckmYZyHHQupEqrKQ6pUpMKC1ch1Jq1DYl_s5ML99zi6pWpZsPLIPueM5xvGXnEoOHDxdiiGXSzKVBbAC6jUE7bhoGQuWlBP2QZkzfOm5PUxex7jAMB508pn7LgUStWqURt2fvXlezaTuXV-9Df7TMdMu0x3w-LMbHeUTaTjEijrfchG_4tCRr_nQJOd99mWQr9E690LdtTrMdLLu_OEfftw_vXsU35x-fHz2fuL3DQg5lxCo6Q2qizrikMvOqOannhnrkXV1wbaupWVKpU0JGohW1nLpurqrgOZ7oCqE3Z6yN0u1xN1htwc9IjbYCcd9ui1xccvzt7ijd-hkCBAyBTw5i4g-J8LxRknGw2No3bkl4i8TZAq4M0q5QepCT7GQP19Gw644scBE35c8SNwTPiT5_XD_907_vJOgncHASVKO0sBo7HkDHU2kJmx8_a_8af_uM1onTV6_EF7ioNfgkv4kWMsEfBq3f-6fi7SVELy6g-4f6s5</recordid><startdate>20160701</startdate><enddate>20160701</enddate><creator>Colvard, Benjamin, MD</creator><creator>Itoga, Nathan K., MD</creator><creator>Hitchner, Elizabeth, MS</creator><creator>Sun, Qingfeng, MD</creator><creator>Long, Becky, MD</creator><creator>Lee, George, MD</creator><creator>Chandra, Venita, MD</creator><creator>Zhou, Wei, MD</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20160701</creationdate><title>SPY technology as an adjunctive measure for lower extremity perfusion</title><author>Colvard, Benjamin, MD ; Itoga, Nathan K., MD ; Hitchner, Elizabeth, MS ; Sun, Qingfeng, MD ; Long, Becky, MD ; Lee, George, MD ; Chandra, Venita, MD ; Zhou, Wei, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c506t-70597ac9224310f6dc95fe1dcb63f4c0848739297ce6467874753d4dd0797c0e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Ankle Brachial Index</topic><topic>Blood Flow Velocity</topic><topic>Critical Illness</topic><topic>Embolism - diagnosis</topic><topic>Embolism - etiology</topic><topic>Embolism - physiopathology</topic><topic>Female</topic><topic>Fluorescein Angiography - instrumentation</topic><topic>Fluorescent Dyes - administration &amp; dosage</topic><topic>Humans</topic><topic>Indocyanine Green - administration &amp; dosage</topic><topic>Injections, Intravenous</topic><topic>Intermittent Claudication - diagnosis</topic><topic>Intermittent Claudication - physiopathology</topic><topic>Intermittent Claudication - therapy</topic><topic>Ischemia - diagnosis</topic><topic>Ischemia - physiopathology</topic><topic>Ischemia - therapy</topic><topic>Lasers</topic><topic>Lower Extremity - blood supply</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Perfusion Imaging - instrumentation</topic><topic>Perfusion Imaging - methods</topic><topic>Peripheral Arterial Disease - diagnosis</topic><topic>Peripheral Arterial Disease - physiopathology</topic><topic>Peripheral Arterial Disease - therapy</topic><topic>Predictive Value of Tests</topic><topic>Prospective Studies</topic><topic>Regional Blood Flow</topic><topic>Reproducibility of Results</topic><topic>Surgery</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><topic>Vascular Patency</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Colvard, Benjamin, MD</creatorcontrib><creatorcontrib>Itoga, Nathan K., MD</creatorcontrib><creatorcontrib>Hitchner, Elizabeth, MS</creatorcontrib><creatorcontrib>Sun, Qingfeng, MD</creatorcontrib><creatorcontrib>Long, Becky, MD</creatorcontrib><creatorcontrib>Lee, George, MD</creatorcontrib><creatorcontrib>Chandra, Venita, MD</creatorcontrib><creatorcontrib>Zhou, Wei, MD</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of vascular surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Colvard, Benjamin, MD</au><au>Itoga, Nathan K., MD</au><au>Hitchner, Elizabeth, MS</au><au>Sun, Qingfeng, MD</au><au>Long, Becky, MD</au><au>Lee, George, MD</au><au>Chandra, Venita, MD</au><au>Zhou, Wei, MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>SPY technology as an adjunctive measure for lower extremity perfusion</atitle><jtitle>Journal of vascular surgery</jtitle><addtitle>J Vasc Surg</addtitle><date>2016-07-01</date><risdate>2016</risdate><volume>64</volume><issue>1</issue><spage>195</spage><epage>201</epage><pages>195-201</pages><issn>0741-5214</issn><eissn>1097-6809</eissn><abstract>Objective Lack of a reliable outcome measure often leads to excessive or insufficient interventions for critical limb ischemia (CLI). SPY technology (Novadaq Technologies Inc, Bonita Springs, Fla), widely adapted by plastic and general surgeons, uses laser-assisted fluorescence angiography (LAFA) to assess tissue perfusion. We sought to determine the role of SPY as an alternative, perhaps more reliable outcome measure for vascular interventions. Methods All patients undergoing elective or urgent revascularization for claudication and CLI were prospectively recruited from June 2012 to August 2014. LAFA using SPY technology was performed before and after revascularization procedures under a standard Institutional Review Board-approved protocol. Quantitative measures of perfusion at plantar surfaces were analyzed and compared with ankle-brachial index. Results A total of 93 patients with claudication or CLI underwent LAFA before and after a revascularization procedure in the study period. The mean preoperative ankle-brachial index increased from 0.60 to 0.84 ( P  &lt; .001) after a revascularization procedure. Plantar perfusion as measured by LAFA also improved significantly after intervention. Ingress, defined as the rate at which fluorescence intensity increases on the plantar surface during LAFA, increased from 7.1 to 12.4 units/s ( P  &lt; .001). Peak perfusion, defined as the difference between the baseline and the peak of fluorescence intensity, increased from 97.1 and 143.9 units ( P  &lt; .001). Egress, defined as the rate at which intensity diminishes after reaching peak perfusion, increased from 1.0 to 1.9 units/s ( P  = .035). Procedure-related digital embolization was also observed in several patients despite lack of an angiographic finding. Conclusions This is the largest prospective study evaluating SPY technology in peripheral vascular interventions. Our study shows that SPY is a valuable tool in visualizing real-time procedural outcomes and providing additionally useful information on regional tissue perfusion. Further investigation is warranted to standardize outpatient use and to determine threshold values that predict wound healing.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>26994959</pmid><doi>10.1016/j.jvs.2016.01.039</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0741-5214
ispartof Journal of vascular surgery, 2016-07, Vol.64 (1), p.195-201
issn 0741-5214
1097-6809
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6706067
source MEDLINE; Elsevier ScienceDirect Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Aged
Aged, 80 and over
Ankle Brachial Index
Blood Flow Velocity
Critical Illness
Embolism - diagnosis
Embolism - etiology
Embolism - physiopathology
Female
Fluorescein Angiography - instrumentation
Fluorescent Dyes - administration & dosage
Humans
Indocyanine Green - administration & dosage
Injections, Intravenous
Intermittent Claudication - diagnosis
Intermittent Claudication - physiopathology
Intermittent Claudication - therapy
Ischemia - diagnosis
Ischemia - physiopathology
Ischemia - therapy
Lasers
Lower Extremity - blood supply
Male
Middle Aged
Perfusion Imaging - instrumentation
Perfusion Imaging - methods
Peripheral Arterial Disease - diagnosis
Peripheral Arterial Disease - physiopathology
Peripheral Arterial Disease - therapy
Predictive Value of Tests
Prospective Studies
Regional Blood Flow
Reproducibility of Results
Surgery
Time Factors
Treatment Outcome
Vascular Patency
title SPY technology as an adjunctive measure for lower extremity perfusion
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T08%3A36%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=SPY%20technology%20as%20an%20adjunctive%20measure%20for%20lower%20extremity%20perfusion&rft.jtitle=Journal%20of%20vascular%20surgery&rft.au=Colvard,%20Benjamin,%20MD&rft.date=2016-07-01&rft.volume=64&rft.issue=1&rft.spage=195&rft.epage=201&rft.pages=195-201&rft.issn=0741-5214&rft.eissn=1097-6809&rft_id=info:doi/10.1016/j.jvs.2016.01.039&rft_dat=%3Cproquest_pubme%3E1800130157%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1800130157&rft_id=info:pmid/26994959&rft_els_id=1_s2_0_S0741521416001671&rfr_iscdi=true